⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

FibroBiologics, Inc. Common Stock

$1.64
-0.06 (-3.53%)

Volume:

67.965K ($109.49K)

Market Capitalization:

$10.92M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

FibroBiologics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.03(+1.86%)
Open$1.61
Close$1.64
Low$1.61
Low Change0.00 (0.00%)
High$1.64
High Change+0.03 (+1.86%)
Range$0.03
Volume2.198K
Dollar Volume$3.60K

Regular Trading Hours

-0.09(-5.29%)
Open$1.70
Close$1.61
Low$1.61
Low Change-0.09 (-5.29%)
High$1.74
High Change+0.04 (+2.10%)
Range$0.13
Volume65.767K
Dollar Volume$105.88K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.03(+1.73%)
Open$1.73
Close$1.76
Low$1.73
Low Change0.00 (0.00%)
High$1.76
High Change+0.03 (+1.73%)
Range$0.03
Volume793
Dollar Volume$1.40K

Regular Trading Hours Yesterday

-0.03(-1.73%)
Open$1.73
Close$1.70
Low$1.67
Low Change-0.06 (-3.39%)
High$1.80
High Change+0.07 (+3.83%)
Range$0.13
Volume78.239K
Dollar Volume$133.01K

Premarket Yesterday

+0.00(+0.00%)
Open$1.64
Close$1.64
Low$1.64
Low Change0.00 (0.00%)
High$1.64
High Change+0.00 (+0.00%)
Range$0.00
Volume407
Dollar Volume$667.48

FibroBiologics Top Trades

FibroBiologics's top trade so far today returned +2.10%, while the top short trade returned -7.24%.

FibroBiologics Moving Averages

5 Day Moving Average (SMA5)$1.76
10 Day Moving Average (SMA10)$1.75
20 Day Moving Average (SMA20)$1.50
50 Day Moving Average (SMA50)$1.10
100 Day Moving Average (SMA100)$1.10
200 Day Moving Average (SMA200)$0.78

FibroBiologics Statistics

Average Volume (30 Days)305.67K
P/E Ratio (Current)-.65
EPS (Current)-$2.72
Dividend Yield0.00%
Free Cash Flow-$14.80M
Cash Ratio1.59
Current Ratio2.64
Quick Ratio2.64
Debt to Equity0.00
Enterprise Value$8.20M
EV to EBITDA-0.52
EV to Sales
Price to Book2.53
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-2.29%
Return on Equity-3.91%

FibroBiologics Stock Splits

There has been 1 stock split for FibroBiologics (FBLG). The reverse stock split occured on March 30, 2026 and reduced the outstanding shares at a ratio of 20:1.

DateTypeRatio
Mar 30, 2026Reverse20:1

FibroBiologics Dividends

There have been no dividends for FibroBiologics (FBLG).